MATTHEW SIROVICH
CIK 1431208 · last filed 2020-11-27
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$534.48M
Companies
6
Total Filings
29
Lifetime Open-Market Net
-$44.06M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| PAVmed Inc. (PAVMZ) Delisted | 10%+ Owner | 2,966,041 | $0.00 | $2.7K | -$755.6K | 5 | 2020-11-27 |
| ITRI | 10%+ Owner | 4,878,384 | $83.93 | $409.44M | $45.05M | 11 | 2019-05-23 |
| Acorda Therapeutics, Inc. (ACOR) Delisted | 10%+ Owner | 42,826 | $0.66 | $28.3K | -$89.77M | 10 | 2019-01-11 |
| Barzel Industries Inc. (TONSW) Delisted | 10%+ Owner | 2,573,409 | — | — | $5.5K | 1 | 2008-10-03 |
| CENT | 10%+ Owner | 2,909,080 | $42.98 | $125.03M | $437.4K | 1 | 2008-04-23 |
| SOURCE INTERLINK COMPANIES INC (SORC) Delisted | 10%+ Owner | 5,421,076 | — | — | $963.7K | 1 | 2008-04-02 |
Recent Filings · Page 2 of 3
29 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2018-12-11 | Acorda Therapeutics, Inc. (ACOR) Delisted | Sell (S) | −240,840 | -$4.56M | EDGAR |
| 2018-12-03 | Acorda Therapeutics, Inc. (ACOR) Delisted | Sell (S) | −900,000 | -$18.46M | EDGAR |
| 2018-11-20 | ITRI | Sell (S) | −75,436 | -$3.95M | EDGAR |
| 2018-07-20 | Acorda Therapeutics, Inc. (ACOR) Delisted | Sell (S) | −434,960 | -$12.65M | EDGAR |
| 2018-07-10 | Acorda Therapeutics, Inc. (ACOR) Delisted | Sell (S) | −801,416 | -$24.53M | EDGAR |
| 2018-06-25 | Acorda Therapeutics, Inc. (ACOR) Delisted | Sell (S) | −241,180 | -$7.36M | EDGAR |
| 2018-06-20 | Acorda Therapeutics, Inc. (ACOR) Delisted | Sell (S) | −1,572,736 | -$48.25M | EDGAR |
| 2018-01-03 | ITRI | Buy (P) | +87,480 | $6.00M | EDGAR |
| 2017-12-18 | ITRI | Buy (P) | +8,640 | $604.0K | EDGAR |
| 2017-12-13 | ITRI | Buy (P) | +53,920 | $3.74M | EDGAR |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.